Carbon-11-NNC 112: A radioligand for PET examination of striatal and neocortical D1-dopamine receptors

Journal of Nuclear Medicine

Volumn 39, Issue 12, 1998, Pages 2061-2068

  Halldin, Christer ^a   Foged, Christian ^b   Chou, Yuan Hwa ^b   Karlsson, Per ^b   Swahn, Carl Gunnar ^b   Sandell, Johan ^b   Sedvall, Göran ^b   Farde, Lars ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Brain; Carbon 11; D1 dopamine receptors; Extrastriatal; Neocortical; NNC 112; PET; Striatal

Indexed keywords

8 CHLORO 5 (7 BENZOFURANYL) 7 HYDROXY 3 METHYL 2,3,4,5 TETRA HYDRO 1H 3 BENZAZEPINE; BENZAZEPINE DERIVATIVE; CARBON 11; DOPAMINE 1 RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; DOPAMINERGIC SYSTEM; DRUG METABOLISM; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MONKEY; NEOCORTEX; NONHUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; STRIATE CORTEX;

ADULT; ANIMALS; BENZAZEPINES; BENZOFURANS; BINDING, COMPETITIVE; CARBON RADIOISOTOPES; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; HUMANS; KINETICS; MACACA FASCICULARIS; MALE; NEOCORTEX; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D1; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032436034     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 11C-raclopride. Psychopharmacology 1987;92: 278-284.
2. Halldin C. Dopamine receptor radioligands. Med Chem Res 1994;5:127-149.
3. Sedvall G, Farde L, Stone-Elander S, Halldin C. Dopamine D-1 receptor binding in the living human brain. In: Breese GR, Creese I, eds. Neurobiology of central D-I dopamine receptors. New York: Plenum; 1986:119-124.
4. 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Appl Radiat Isot 1986;37:1039-1043.
5. 11C]raclopride. Psychopharmacology 1992;107:23-29.
6. 3H-raclopride J Neural Transm 1988;73:7-21.
7. 3H]raclopride. Proc Natl Acad Sci USA 1989;86:6412-6416.
8. Lidow MS, Goldman-Rakic PS. A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proc Natl Acad Sci USA 1994;91:4353-4356.
9. Okubo Y, Suhara T, Suzuki K, et al. Decreased prefrontal dopamine receptors in schizophrenia revealed by PET. Nature 1997;385:634-636.
10. 1 receptor antagonists. Eur J Pharmacol 1992;219:35-44.
11. 1 receptor antagonists. Eur J Pharmacol 1992;219:45-52.
12. 11C]NNC 112, a selective PET radioligand for examination of extrastriatal dopamine D1 receptors [Abstract]. J Nucl Med 1994;35:122P.
13. 11C]raclopride binding to D2-dopamine receptors studied by PET - a comparison to the saturation analysis. J Cerebr Blood Flow Melab 1989;9:696-708.
14. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cerebr Blood Flow Metab 1990;10:740-747.
15. 11C-Labelling of eticlopride in two different positions - a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. Appl Radiat Isot 1990;41:669-674.
16. 11C]methyl triflate. Appl Radiat Isot 1992;43:1383-1385.
17. 11C]methyl triflate. Nucl Med Biol 1995;22:235-239.
18. 11C]methyl triflate. J Labelled Compd Radiopharm 1998;41:545-556.
19. Olofson RA. A new reagent for the selective, high-yield N-dealkylation of tertiary amines: improved syntheses of naltrexone and nalbuphine. J Org Chem 1984;49:2081-2082.
20. Litton J, Holte S, Eriksson L. Evaluation of the Karolinska new positron camera system; the Scanditronix PC2048-15B. IEEE Trans Nucl Sci 1990;37:743-748.
21. Wienhard K, Dahlbom M, Eriksson L, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994;18:110-118.
22. 11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology 1993;113:149-156.
23. Bergström M, Boëthius J, Eriksson L, Greitz T, Ribbe T, Widén L. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 1981;5:136-141.
24. Eriksson L, Holte S, Bohm C, Kesselberg M, Hovander B. Automated blood sampling system for positron emission tomography. IEEE Trans Nucl Sci 1988;35:703-707.
25. Halldin C, Swahn C-G, Farde L, Sedvall G. Radioligand disposition and metabolism. Key information in early drug development. In: Comar D, ed. PET for drug development and evaluation. Dordrecht: Kluwer Academic Publishers; 1995:55-65.
26. 11C]SCH 23390. Identification of two metabolites with HPLC. Hum Psychopharmacol 1994;9: 25-31.
27. 11C-labelled dopamine antagonists, raclopride, SCH 23390 and N-methylspiroperidol. Hum Psychopharmacol 1992;7:97-103.
28. Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations. Appl Radiat Isot 1991;42:451-455.
29. 11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey. Nucl Med Biol 1993;20:945-953.
30. 76Br-labelled NNC 22-0010, selective dopamine D-1 receptor ligands for PET. Nucl Med Biol 1996;23:837-844.
31. Halldin C, Farde L, Högberg T, et al. A comparative PET study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 binding. Nucl Med Biol 1991;18:871-881.
32. 11C-raclopride in living human brain - a search for extrastriatal central D2-dopamine receptors by PET. Psychopharmacology 1988;94:471-478.